The NEC patients were older than NET G3 patients, exhibited a higher Ki-67 labeling index, and more frequently showed a solid growth pattern, whereas NET G3 patients more commonly displayed an organoid growth pattern (Tables 1 and 2). This evidence concerns the gene MKI67 and neuroendocrine carcinoma.